Recruiting
Phase 1

CAR-T Cell Therapy

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT06056102

Conditions

Kidney Transplant

Kidney Failure

End Stage Renal Failure on Dialysis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

CART-BCMA

huCART19

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-19. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2025-08-05.